Explore how the 30-month stay under the Hatch-Waxman Act delays generic drug approval through patent litigation. Learn about Paragraph IV certifications, economic impacts, and upcoming reforms.
Explore how the 30-month stay under the Hatch-Waxman Act delays generic drug approval through patent litigation. Learn about Paragraph IV certifications, economic impacts, and upcoming reforms.
Learn how FDA therapeutic equivalency codes determine if generic drugs can substitute brand names. Explore the Orange Book, A vs B ratings, and state laws.
Discover how the entry of second and third generic manufacturers drastically cuts drug prices, breaking brand monopolies and saving consumers billions.
Compare costs of authorized generics vs first-to-file generics. See how FTC data shows price drops, revenue impacts, and market strategies affect your medication bill.
Health Policy, Medicines and Supplements
